Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments

Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments

US Patent 7629364 · Granted Dec 8, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phosphatidylserine-binding conjugates2025
IDO/TDO inhibitor2025
Daisy chain connection system and system control method2021
Peptides and peptidomimetics in combination with t cell activating and/or checkp2018
Interlocking structure, mounting member, and airbag device2016
Peptides and peptidomimetics in combination uses and treatments for cancer patie2015
Compounds with anti-cancer activity2013
Compounds with anti-cancer activity2011
Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cel2010
Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augme2010
Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augme2010
Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and an2009